Skip to main content
. 2021 Nov 16;12:768989. doi: 10.3389/fimmu.2021.768989

Figure 1.

Figure 1

NKp46+ ILCs are dispensable for the immunosurveillance of MCA-induced tumors. Mice of the indicated genotype (A) or intravenously injected with PK136 antibody to deplete NK1.1+ cells (B) received a single subcutaneous injection of MCA at the indicated doses. Sarcoma formation was weekly monitored for 200 days. Tumor-bearing mice were defined as mice harboring masses increasing in size for at least two consecutive measurements. The p-values for LogRank tests are indicated.